ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesD03.6

D03.6

Billable

Melanoma in situ of upper limb, including shoulder

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D03.6 is a billable code used to indicate a diagnosis of melanoma in situ of upper limb, including shoulder.

Key Diagnostic Point:

Melanoma in situ of the upper limb, including the shoulder, is a localized form of skin cancer characterized by the presence of atypical melanocytes confined to the epidermis. This condition is considered a precursor to invasive melanoma and is often asymptomatic in its early stages. Patients may present with a pigmented lesion that has irregular borders and varied coloration. Diagnosis typically involves a biopsy, which confirms the presence of atypical melanocytes without invasion into the dermis. Surveillance is critical, as melanoma in situ can progress to invasive melanoma if left untreated. Treatment options include surgical excision, which is the standard approach, and careful monitoring for any changes in the lesion. Regular follow-up appointments are essential for assessing the risk of progression and ensuring early intervention if necessary. The prognosis for melanoma in situ is generally favorable with appropriate management, but patient education on self-examination and sun protection is vital to prevent recurrence and new lesions.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiation from other skin lesions
  • Need for precise documentation of lesion characteristics
  • Potential for progression to invasive melanoma
  • Variability in treatment approaches

Audit Risk Factors

  • Inadequate documentation of lesion characteristics
  • Failure to document biopsy results
  • Lack of follow-up notes
  • Misclassification of the lesion type

Specialty Focus

Medical Specialties

Dermatology

Documentation Requirements

Detailed description of the lesion, biopsy results, and treatment plan.

Common Clinical Scenarios

Patients presenting with suspicious skin lesions requiring biopsy.

Billing Considerations

Ensure accurate documentation of lesion size, location, and characteristics to support coding.

Oncology

Documentation Requirements

Comprehensive treatment history and follow-up care plans.

Common Clinical Scenarios

Management of patients with a history of melanoma in situ and monitoring for recurrence.

Billing Considerations

Document any changes in the patient's condition or new lesions thoroughly.

Coding Guidelines

Inclusion Criteria

Use D03.6 When
  • According to ICD
  • 10 coding guidelines, D03
  • 6 should be used when the melanoma is confirmed to be in situ and localized to the upper limb
  • It is essential to document the specific site and characteristics of the lesion

Exclusion Criteria

Do NOT use D03.6 When
  • Exclusions include any invasive melanoma or lesions located in other body parts

Related ICD-10 Codes

Related CPT Codes

11600CPT Code

Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter over 4.0 cm

Clinical Scenario

Used when excising a melanoma in situ from the upper limb.

Documentation Requirements

Document the size of the lesion and the excised diameter.

Specialty Considerations

Dermatologists should ensure clear documentation of the excision site and pathology results.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of melanoma in situ, improving the accuracy of data collection and treatment tracking. This specificity aids in better patient management and research outcomes.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of melanoma in situ, improving the accuracy of data collection and treatment tracking. This specificity aids in better patient management and research outcomes.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of melanoma in situ, improving the accuracy of data collection and treatment tracking. This specificity aids in better patient management and research outcomes.

Resources

Clinical References

  • •
    American Academy of Dermatology

Coding & Billing References

  • •
    American Academy of Dermatology

Frequently Asked Questions

What is the difference between melanoma in situ and invasive melanoma?

Melanoma in situ is confined to the epidermis and has not invaded the dermis, while invasive melanoma has penetrated deeper layers of skin and may metastasize.